TNDM Q3 2022 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$205M+13.9% YoY

Gross Profit

$104M51.1% margin

Operating Income

-$47M-23.2% margin

Net Income

-$49M-23.9% margin

EPS (Diluted)

$-0.76

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$10M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$626M

Stockholders' Equity

$422M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$205M	$180M	+13.9%
Gross Profit	$104M	$97M	+7.9%
Operating Income	-$47M	$8M	-715.2%
Net Income	-$49M	$6M	-945.2%

Geographic Segments

UNITED STATES

$146M71%

Non-US

$59M29%